RM3.04 or RM4.00 are both very low prices, worth buying! Because Careplus and its partner Ansell attach great importance to labor, the company can develop steadily! Worth a long-term investment!

HLT stock price will keep rising

You sold it too early, you must regret it!

Because it is impossible to drop prices!

So I don’t want to sell!

I believe RM1.00 is coming soon!

Careplus stock price will keep rising

You sold it too early, you must regret it!

Because it is impossible to drop prices!

So I don’t want to sell!

I believe RM4.00 is coming soon!

U.S. News

The leaders of the eight nations of the world called on all countries in the world to have equal access to vaccines. Public health experts said that a WHO-like mechanism is needed to coordinate global vaccine distribution.

Global vaccine research and development scrambling

At present, scientists and researchers all over the world are scrambling to develop effective vaccines against the new coronavirus. Under the World Health Organization (WHO) tracking, there are more than 140 vaccine candidates under development. Under normal circumstances, the development of an effective and safe vaccine requires several years of testing and additional time for large-scale production; given that the new coronavirus is still raging in many countries around the world, scientists hope to be able to develop it within 12 to 18 months The coronavirus vaccine.

Up to now, there are three new coronavirus vaccines in the world, which are developed by the University of Oxford/AstraZeneca in the UK, Sinovac Biotech in China, and Moderna in the United States. Development.

The leaders of the eight countries in the world called for the successful development of the new crown vaccine, it is necessary to ensure that the world can obtain and enjoy the vaccine on an equal basis. The eight countries where the leaders jointly published articles are: Canada, South Korea, New Zealand, Ethiopia, South Africa, Spain, Sweden and Tunisia.

American public health expert Huang Yanzhong believes that the international community is currently facing two problems: First, there has not been any sign that countries (that are capable of developing vaccines) agree to let the World Health Organization allocate it, or that the World Health Organization has at least one Solution: For example, the country that first developed the vaccine would give a part of the vaccine produced, such as donating 10% to the World Health Organization, which is responsible for distribution to poor or developing countries.

"As far as I know, the international community has not yet reached any consensus on this issue," Huang Yanzhong said. "Another important issue is that the US government no longer trusts the WHO and has officially announced that it will withdraw from the World Health Organization next year. "It is generally believed that if the United States launches a vaccine first, it will vaccinate the American people first.

Due to the high cost of developing vaccines, based on interest considerations, it is impossible for pharmaceutical companies or countries that develop vaccines to cooperate with or even contract to developing countries. This is also the reason why the international community cannot reach a consensus.

Dr. Laura H. Kahn (MD) of Princeton University said that she is not sure whether the American people will be willing to queue up for the new coronavirus vaccine by then. She expressed concern about this. "We have noticed that many people generally do not have confidence in vaccines or even science. This is a very serious public health problem because vaccines are the best strategy for us to control the epidemic," she said.

American public health expert Huang Yanzhong said that the low level of acceptance of vaccines by the American public is one of the most difficult problems in preventing and controlling the new crown epidemic. Due to political, social, religious and cultural reasons, the US government cannot force the entire population to be vaccinated.

On the other hand, Dr. Kahn told VOA: “I don’t think we should have any hope of getting a vaccine in the near future. We hope that the vaccine will not only be effective but also safe, and it will take a long time to ensure both. ."

美国新闻

世界八国领导人呼吁世界各国平等获得疫苗的权利。公共卫生专家表示，需要一个类似世卫组织的机制来协调全球疫苗的分配。

全球疫苗研发争先恐后

目前全世界的科学家和研究人员正在争先恐后地研发针对新冠病毒的有效疫苗，在世界卫生组织（WHO）跟踪下的就有140多家候选疫苗在研发中。通常情况下，一种有效、安全疫苗的研发需要数年的试验，以及额外的时间投入大规模生产；鉴于目前新冠病毒仍在全球许多国家肆虐，科学家们希望能够在12至18个月内研制出冠状病毒疫苗。

截至目前，全球已经有三支新冠病毒疫苗处于世界领先地位，分别由英国的牛津大学（University of Oxford/AstraZeneca）、中国的科兴生物技术（Sinovac Biotech），以及美国的（Moderna）生物技术公司开发研制。

世界八国领导人呼吁，在新冠疫苗研发成功后，必须保证全球能够平等地获得和享用疫苗。领导人联名发表文章的这八个国家是：加拿大、韩国、新西兰、埃塞俄比亚、南非、西班牙、瑞典和突尼斯。

美国公共卫生专家黄严忠认为，目前国际社会面临两个问题：首先，还没有看到任何迹象显示各个（有能力研发疫苗的）国家同意来让世界卫生组织分配，或者由世卫组织至少订出一个方案：比如，首先研发出疫苗的国家，把所生产的疫苗拿出一部分，比如10%捐赠给世界卫生组织，由世界卫生组织负责给那些贫穷或者发展中的国家配送。

“据我所知，目前国际社会还没有就这个问题有任何共识，”黄严忠说，“另外一个重要的问题，就是美国政府现在已经不信任世卫组织，并且正式宣布明年将退出世界卫生组织。”普遍认为美国要是先推出疫苗，将会先给美国人民注射疫苗。

由于研发疫苗需要耗费很大成本，基于利益考量，那些研发疫苗的药厂或者国家不可能与发展中的国家合作甚至让发展中的国家承包。这也是国际社会不能达成共识的原因。

普林斯顿大学的卡恩医生（Laura H. Kahn, MD）表示，不能确定美国民众届时是否愿意去排队接种新冠病毒疫苗，她对此表示担忧。“我们注意到目前许多人普遍对疫苗没有信心，甚至对科学也不信任。这是一个非常严重的公共卫生问题，因为疫苗是我们能够控制疾病流行的最佳策略，” 她说。

美国公共卫生专家黄严忠说，美国公众对疫苗的接受程度低，是防控新冠疫情的最棘手的问题之一。由于政治、社会和宗教文化等诸多方面的原因，美国政府不能强制全民接种疫苗。

另一方面，卡恩医生对美国之音说：“我认为我们不应抱有能在近期获得疫苗的希望。我们希望疫苗不仅要有效，而且要安全，而要确保这两者需要很长时间。”

U.S. News

The leaders of the eight nations of the world called on all countries in the world to have equal access to vaccines. Public health experts said that a WHO-like mechanism is needed to coordinate global vaccine distribution.

Global vaccine research and development scrambling

At present, scientists and researchers all over the world are scrambling to develop effective vaccines against the new coronavirus. Under the World Health Organization (WHO) tracking, there are more than 140 vaccine candidates under development. Under normal circumstances, the development of an effective and safe vaccine requires several years of testing and additional time for large-scale production; given that the new coronavirus is still raging in many countries around the world, scientists hope to be able to develop it within 12 to 18 months The coronavirus vaccine.

Up to now, there are three new coronavirus vaccines in the world, which are developed by the University of Oxford/AstraZeneca in the UK, Sinovac Biotech in China, and Moderna in the United States. Development.

The leaders of the eight countries in the world called for the successful development of the new crown vaccine, it is necessary to ensure that the world can obtain and enjoy the vaccine on an equal basis. The eight countries where the leaders jointly published articles are: Canada, South Korea, New Zealand, Ethiopia, South Africa, Spain, Sweden and Tunisia.

American public health expert Huang Yanzhong believes that the international community is currently facing two problems: First, there has not been any sign that countries (that are capable of developing vaccines) agree to let the World Health Organization allocate it, or that the World Health Organization has at least one Solution: For example, the country that first developed the vaccine would give a part of the vaccine produced, such as donating 10% to the World Health Organization, which is responsible for distribution to poor or developing countries.

"As far as I know, the international community has not yet reached any consensus on this issue," Huang Yanzhong said. "Another important issue is that the US government no longer trusts the WHO and has officially announced that it will withdraw from the World Health Organization next year. "It is generally believed that if the United States launches a vaccine first, it will vaccinate the American people first.

Due to the high cost of developing vaccines, based on interest considerations, it is impossible for pharmaceutical companies or countries that develop vaccines to cooperate with or even contract to developing countries. This is also the reason why the international community cannot reach a consensus.

Dr. Laura H. Kahn (MD) of Princeton University said that she is not sure whether the American people will be willing to queue up for the new coronavirus vaccine by then. She expressed concern about this. "We have noticed that many people generally do not have confidence in vaccines or even science. This is a very serious public health problem because vaccines are the best strategy for us to control the epidemic," she said.

American public health expert Huang Yanzhong said that the low level of acceptance of vaccines by the American public is one of the most difficult problems in preventing and controlling the new crown epidemic. Due to political, social, religious and cultural reasons, the US government cannot force the entire population to be vaccinated.

On the other hand, Dr. Kahn told VOA: “I don’t think we should have any hope of getting a vaccine in the near future. We hope that the vaccine will not only be effective but also safe, and it will take a long time to ensure both. ."

美国新闻

世界八国领导人呼吁世界各国平等获得疫苗的权利。公共卫生专家表示，需要一个类似世卫组织的机制来协调全球疫苗的分配。

全球疫苗研发争先恐后

目前全世界的科学家和研究人员正在争先恐后地研发针对新冠病毒的有效疫苗，在世界卫生组织（WHO）跟踪下的就有140多家候选疫苗在研发中。通常情况下，一种有效、安全疫苗的研发需要数年的试验，以及额外的时间投入大规模生产；鉴于目前新冠病毒仍在全球许多国家肆虐，科学家们希望能够在12至18个月内研制出冠状病毒疫苗。

截至目前，全球已经有三支新冠病毒疫苗处于世界领先地位，分别由英国的牛津大学（University of Oxford/AstraZeneca）、中国的科兴生物技术（Sinovac Biotech），以及美国的（Moderna）生物技术公司开发研制。

世界八国领导人呼吁，在新冠疫苗研发成功后，必须保证全球能够平等地获得和享用疫苗。领导人联名发表文章的这八个国家是：加拿大、韩国、新西兰、埃塞俄比亚、南非、西班牙、瑞典和突尼斯。

美国公共卫生专家黄严忠认为，目前国际社会面临两个问题：首先，还没有看到任何迹象显示各个（有能力研发疫苗的）国家同意来让世界卫生组织分配，或者由世卫组织至少订出一个方案：比如，首先研发出疫苗的国家，把所生产的疫苗拿出一部分，比如10%捐赠给世界卫生组织，由世界卫生组织负责给那些贫穷或者发展中的国家配送。

“据我所知，目前国际社会还没有就这个问题有任何共识，”黄严忠说，“另外一个重要的问题，就是美国政府现在已经不信任世卫组织，并且正式宣布明年将退出世界卫生组织。”普遍认为美国要是先推出疫苗，将会先给美国人民注射疫苗。

由于研发疫苗需要耗费很大成本，基于利益考量，那些研发疫苗的药厂或者国家不可能与发展中的国家合作甚至让发展中的国家承包。这也是国际社会不能达成共识的原因。

普林斯顿大学的卡恩医生（Laura H. Kahn, MD）表示，不能确定美国民众届时是否愿意去排队接种新冠病毒疫苗，她对此表示担忧。“我们注意到目前许多人普遍对疫苗没有信心，甚至对科学也不信任。这是一个非常严重的公共卫生问题，因为疫苗是我们能够控制疾病流行的最佳策略，” 她说。

美国公共卫生专家黄严忠说，美国公众对疫苗的接受程度低，是防控新冠疫情的最棘手的问题之一。由于政治、社会和宗教文化等诸多方面的原因，美国政府不能强制全民接种疫苗。

另一方面，卡恩医生对美国之音说：“我认为我们不应抱有能在近期获得疫苗的希望。我们希望疫苗不仅要有效，而且要安全，而要确保这两者需要很长时间。”

U.S. News

The leaders of the eight nations of the world called on all countries in the world to have equal access to vaccines. Public health experts said that a WHO-like mechanism is needed to coordinate global vaccine distribution.

Global vaccine research and development scrambling

At present, scientists and researchers all over the world are scrambling to develop effective vaccines against the new coronavirus. Under the World Health Organization (WHO) tracking, there are more than 140 vaccine candidates under development. Under normal circumstances, the development of an effective and safe vaccine requires several years of testing and additional time for large-scale production; given that the new coronavirus is still raging in many countries around the world, scientists hope to be able to develop it within 12 to 18 months The coronavirus vaccine.

Up to now, there are three new coronavirus vaccines in the world, which are developed by the University of Oxford/AstraZeneca in the UK, Sinovac Biotech in China, and Moderna in the United States. Development.

The leaders of the eight countries in the world called for the successful development of the new crown vaccine, it is necessary to ensure that the world can obtain and enjoy the vaccine on an equal basis. The eight countries where the leaders jointly published articles are: Canada, South Korea, New Zealand, Ethiopia, South Africa, Spain, Sweden and Tunisia.

American public health expert Huang Yanzhong believes that the international community is currently facing two problems: First, there has not been any sign that countries (that are capable of developing vaccines) agree to let the World Health Organization allocate it, or that the World Health Organization has at least one Solution: For example, the country that first developed the vaccine would give a part of the vaccine produced, such as donating 10% to the World Health Organization, which is responsible for distribution to poor or developing countries.

"As far as I know, the international community has not yet reached any consensus on this issue," Huang Yanzhong said. "Another important issue is that the US government no longer trusts the WHO and has officially announced that it will withdraw from the World Health Organization next year. "It is generally believed that if the United States launches a vaccine first, it will vaccinate the American people first.

Due to the high cost of developing vaccines, based on interest considerations, it is impossible for pharmaceutical companies or countries that develop vaccines to cooperate with or even contract to developing countries. This is also the reason why the international community cannot reach a consensus.

Dr. Laura H. Kahn (MD) of Princeton University said that she is not sure whether the American people will be willing to queue up for the new coronavirus vaccine by then. She expressed concern about this. "We have noticed that many people generally do not have confidence in vaccines or even science. This is a very serious public health problem because vaccines are the best strategy for us to control the epidemic," she said.

American public health expert Huang Yanzhong said that the low level of acceptance of vaccines by the American public is one of the most difficult problems in preventing and controlling the new crown epidemic. Due to political, social, religious and cultural reasons, the US government cannot force the entire population to be vaccinated.

On the other hand, Dr. Kahn told VOA: “I don’t think we should have any hope of getting a vaccine in the near future. We hope that the vaccine will not only be effective but also safe, and it will take a long time to ensure both. ."

美国新闻

世界八国领导人呼吁世界各国平等获得疫苗的权利。公共卫生专家表示，需要一个类似世卫组织的机制来协调全球疫苗的分配。

全球疫苗研发争先恐后

目前全世界的科学家和研究人员正在争先恐后地研发针对新冠病毒的有效疫苗，在世界卫生组织（WHO）跟踪下的就有140多家候选疫苗在研发中。通常情况下，一种有效、安全疫苗的研发需要数年的试验，以及额外的时间投入大规模生产；鉴于目前新冠病毒仍在全球许多国家肆虐，科学家们希望能够在12至18个月内研制出冠状病毒疫苗。

截至目前，全球已经有三支新冠病毒疫苗处于世界领先地位，分别由英国的牛津大学（University of Oxford/AstraZeneca）、中国的科兴生物技术（Sinovac Biotech），以及美国的（Moderna）生物技术公司开发研制。

世界八国领导人呼吁，在新冠疫苗研发成功后，必须保证全球能够平等地获得和享用疫苗。领导人联名发表文章的这八个国家是：加拿大、韩国、新西兰、埃塞俄比亚、南非、西班牙、瑞典和突尼斯。

美国公共卫生专家黄严忠认为，目前国际社会面临两个问题：首先，还没有看到任何迹象显示各个（有能力研发疫苗的）国家同意来让世界卫生组织分配，或者由世卫组织至少订出一个方案：比如，首先研发出疫苗的国家，把所生产的疫苗拿出一部分，比如10%捐赠给世界卫生组织，由世界卫生组织负责给那些贫穷或者发展中的国家配送。

“据我所知，目前国际社会还没有就这个问题有任何共识，”黄严忠说，“另外一个重要的问题，就是美国政府现在已经不信任世卫组织，并且正式宣布明年将退出世界卫生组织。”普遍认为美国要是先推出疫苗，将会先给美国人民注射疫苗。

由于研发疫苗需要耗费很大成本，基于利益考量，那些研发疫苗的药厂或者国家不可能与发展中的国家合作甚至让发展中的国家承包。这也是国际社会不能达成共识的原因。

普林斯顿大学的卡恩医生（Laura H. Kahn, MD）表示，不能确定美国民众届时是否愿意去排队接种新冠病毒疫苗，她对此表示担忧。“我们注意到目前许多人普遍对疫苗没有信心，甚至对科学也不信任。这是一个非常严重的公共卫生问题，因为疫苗是我们能够控制疾病流行的最佳策略，” 她说。

美国公共卫生专家黄严忠说，美国公众对疫苗的接受程度低，是防控新冠疫情的最棘手的问题之一。由于政治、社会和宗教文化等诸多方面的原因，美国政府不能强制全民接种疫苗。

另一方面，卡恩医生对美国之音说：“我认为我们不应抱有能在近期获得疫苗的希望。我们希望疫苗不仅要有效，而且要安全，而要确保这两者需要很长时间。”

U.S. News

The leaders of the eight nations of the world called on all countries in the world to have equal access to vaccines. Public health experts said that a WHO-like mechanism is needed to coordinate global vaccine distribution.

Global vaccine research and development scrambling

At present, scientists and researchers all over the world are scrambling to develop effective vaccines against the new coronavirus. Under the World Health Organization (WHO) tracking, there are more than 140 vaccine candidates under development. Under normal circumstances, the development of an effective and safe vaccine requires several years of testing and additional time for large-scale production; given that the new coronavirus is still raging in many countries around the world, scientists hope to be able to develop it within 12 to 18 months The coronavirus vaccine.

Up to now, there are three new coronavirus vaccines in the world, which are developed by the University of Oxford/AstraZeneca in the UK, Sinovac Biotech in China, and Moderna in the United States. Development.

The leaders of the eight countries in the world called for the successful development of the new crown vaccine, it is necessary to ensure that the world can obtain and enjoy the vaccine on an equal basis. The eight countries where the leaders jointly published articles are: Canada, South Korea, New Zealand, Ethiopia, South Africa, Spain, Sweden and Tunisia.

American public health expert Huang Yanzhong believes that the international community is currently facing two problems: First, there has not been any sign that countries (that are capable of developing vaccines) agree to let the World Health Organization allocate it, or that the World Health Organization has at least one Solution: For example, the country that first developed the vaccine would give a part of the vaccine produced, such as donating 10% to the World Health Organization, which is responsible for distribution to poor or developing countries.

"As far as I know, the international community has not yet reached any consensus on this issue," Huang Yanzhong said. "Another important issue is that the US government no longer trusts the WHO and has officially announced that it will withdraw from the World Health Organization next year. "It is generally believed that if the United States launches a vaccine first, it will vaccinate the American people first.

Due to the high cost of developing vaccines, based on interest considerations, it is impossible for pharmaceutical companies or countries that develop vaccines to cooperate with or even contract to developing countries. This is also the reason why the international community cannot reach a consensus.

Dr. Laura H. Kahn (MD) of Princeton University said that she is not sure whether the American people will be willing to queue up for the new coronavirus vaccine by then. She expressed concern about this. "We have noticed that many people generally do not have confidence in vaccines or even science. This is a very serious public health problem because vaccines are the best strategy for us to control the epidemic," she said.

American public health expert Huang Yanzhong said that the low level of acceptance of vaccines by the American public is one of the most difficult problems in preventing and controlling the new crown epidemic. Due to political, social, religious and cultural reasons, the US government cannot force the entire population to be vaccinated.

On the other hand, Dr. Kahn told VOA: “I don’t think we should have any hope of getting a vaccine in the near future. We hope that the vaccine will not only be effective but also safe, and it will take a long time to ensure both. ."

美国新闻

世界八国领导人呼吁世界各国平等获得疫苗的权利。公共卫生专家表示，需要一个类似世卫组织的机制来协调全球疫苗的分配。

全球疫苗研发争先恐后

目前全世界的科学家和研究人员正在争先恐后地研发针对新冠病毒的有效疫苗，在世界卫生组织（WHO）跟踪下的就有140多家候选疫苗在研发中。通常情况下，一种有效、安全疫苗的研发需要数年的试验，以及额外的时间投入大规模生产；鉴于目前新冠病毒仍在全球许多国家肆虐，科学家们希望能够在12至18个月内研制出冠状病毒疫苗。

截至目前，全球已经有三支新冠病毒疫苗处于世界领先地位，分别由英国的牛津大学（University of Oxford/AstraZeneca）、中国的科兴生物技术（Sinovac Biotech），以及美国的（Moderna）生物技术公司开发研制。

世界八国领导人呼吁，在新冠疫苗研发成功后，必须保证全球能够平等地获得和享用疫苗。领导人联名发表文章的这八个国家是：加拿大、韩国、新西兰、埃塞俄比亚、南非、西班牙、瑞典和突尼斯。

美国公共卫生专家黄严忠认为，目前国际社会面临两个问题：首先，还没有看到任何迹象显示各个（有能力研发疫苗的）国家同意来让世界卫生组织分配，或者由世卫组织至少订出一个方案：比如，首先研发出疫苗的国家，把所生产的疫苗拿出一部分，比如10%捐赠给世界卫生组织，由世界卫生组织负责给那些贫穷或者发展中的国家配送。

“据我所知，目前国际社会还没有就这个问题有任何共识，”黄严忠说，“另外一个重要的问题，就是美国政府现在已经不信任世卫组织，并且正式宣布明年将退出世界卫生组织。”普遍认为美国要是先推出疫苗，将会先给美国人民注射疫苗。

由于研发疫苗需要耗费很大成本，基于利益考量，那些研发疫苗的药厂或者国家不可能与发展中的国家合作甚至让发展中的国家承包。这也是国际社会不能达成共识的原因。

普林斯顿大学的卡恩医生（Laura H. Kahn, MD）表示，不能确定美国民众届时是否愿意去排队接种新冠病毒疫苗，她对此表示担忧。“我们注意到目前许多人普遍对疫苗没有信心，甚至对科学也不信任。这是一个非常严重的公共卫生问题，因为疫苗是我们能够控制疾病流行的最佳策略，” 她说。

美国公共卫生专家黄严忠说，美国公众对疫苗的接受程度低，是防控新冠疫情的最棘手的问题之一。由于政治、社会和宗教文化等诸多方面的原因，美国政府不能强制全民接种疫苗。

另一方面，卡恩医生对美国之音说：“我认为我们不应抱有能在近期获得疫苗的希望。我们希望疫苗不仅要有效，而且要安全，而要确保这两者需要很长时间。”

The rise in pharmaceutical stocks is only temporary and will fall soon.

Because foreign countries have not yet introduced a vaccine, and the vaccine validity period can only last for one year.

Many poor people in the world do not have the financial means to vaccinate, and it is even more impossible to vaccinate every year.

What's more, the new coronavirus has been mutating.

Only glove stocks have long-term investment value.

Because of the increase in the world's population, the demand for gloves is increasing.

医药股上升只是暂时的，很快会下跌。

因为外国还没有推出疫苗，而且疫苗有效期只可以维持一年。

全世界很多穷人没有经济能力注射疫苗，更加不可能每一年注射。

何况，新冠病毒一直变种。

只有手套股才有长久的投资价值。

因为全世界人口增多，手套需求量有增无减。

The rise in pharmaceutical stocks is only temporary and will fall soon.

Because foreign countries have not yet introduced a vaccine, and the vaccine validity period can only last for one year.

Many poor people in the world do not have the financial means to vaccinate, and it is even more impossible to vaccinate every year.

What's more, the new coronavirus has been mutating.

Only glove stocks have long-term investment value.

Because of the increase in the world's population, the demand for gloves is increasing.

医药股上升只是暂时的，很快会下跌。

因为外国还没有推出疫苗，而且疫苗有效期只可以维持一年。

全世界很多穷人没有经济能力注射疫苗，更加不可能每一年注射。

何况，新冠病毒一直变种。

只有手套股才有长久的投资价值。

因为全世界人口增多，手套需求量有增无减。

The rise in pharmaceutical stocks is only temporary and will fall soon.

Because foreign countries have not yet introduced a vaccine, and the vaccine validity period can only last for one year.

Many poor people in the world do not have the financial means to vaccinate, and it is even more impossible to vaccinate every year.

What's more, the new coronavirus has been mutating.

Only glove stocks have long-term investment value.

Because of the increase in the world's population, the demand for gloves is increasing.

医药股上升只是暂时的，很快会下跌。

因为外国还没有推出疫苗，而且疫苗有效期只可以维持一年。

全世界很多穷人没有经济能力注射疫苗，更加不可能每一年注射。

何况，新冠病毒一直变种。

只有手套股才有长久的投资价值。

因为全世界人口增多，手套需求量有增无减。

The rise in pharmaceutical stocks is only temporary and will fall soon.

Because foreign countries have not yet introduced a vaccine, and the vaccine validity period can only last for one year.

Many poor people in the world do not have the financial means to vaccinate, and it is even more impossible to vaccinate every year.

What's more, the new coronavirus has been mutating.

Only glove stocks have long-term investment value.

Because of the increase in the world's population, the demand for gloves is increasing.

医药股上升只是暂时的，很快会下跌。

因为外国还没有推出疫苗，而且疫苗有效期只可以维持一年。

全世界很多穷人没有经济能力注射疫苗，更加不可能每一年注射。

何况，新冠病毒一直变种。

只有手套股才有长久的投资价值。

因为全世界人口增多，手套需求量有增无减。

Today the superman flies down and finally flies up again

Look forward to flying tomorrow

Hope to fly to RM20.00

Now only the glove stock can rise

Kossan took me to fly

wakakakakaka

Now only the glove stock can rise

Superman takes me to fly

wakakakakaka

Careplus is crazy! I missed it before, now I have to grasp it!

Hope to get RM4.00

wakakakakaka

美国国家过敏和传染病研究所所长Anthony Fauci担忧新冠病毒的潜在疫苗恐“耐用性不佳”，他认为新冠疫苗恐怕无法提供长效免疫力。

据美国全国广播公司商业频道(CNBC)2日报道，Anthony Fauci接受了《美国医学会杂志》(JAMA)编辑Howard Bauchner教授采访时指出，假使新冠病毒像以往其他冠状病毒一样的话，那么新冠疫苗带来的免疫持续时间不会很长，有效期只可以维持半年或者一年。

Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases of the United States, is concerned that the potential vaccine for the new crown virus may be "poorly durable". He believes that the new crown vaccine may not provide long-term immunity.

According to a CNBC report on the 2nd, Anthony Fauci was interviewed by Professor Howard Bauchner, editor of the Journal of the American Medical Association (JAMA), and pointed out that if the new coronavirus is like other coronaviruses in the past, then the new coronavirus vaccine The duration of immunization will not be very long, and the validity period can only last for six months or one year.

Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases of the United States, is concerned that the potential vaccine for the new crown virus may be "poorly durable". He believes that the new crown vaccine may not provide long-term immunity.

According to a CNBC report on the 2nd, Anthony Fauci was interviewed by Professor Howard Bauchner, editor of the Journal of the American Medical Association (JAMA), and pointed out that if the new coronavirus is like other coronaviruses in the past, then the new coronavirus vaccine The duration of immunization will not be very long, and the validity period can only last for six months or one year.

美国国家过敏和传染病研究所所长Anthony Fauci担忧新冠病毒的潜在疫苗恐“耐用性不佳”，他认为新冠疫苗恐怕无法提供长效免疫力。

据美国全国广播公司商业频道(CNBC)2日报道，Anthony Fauci接受了《美国医学会杂志》(JAMA)编辑Howard Bauchner教授采访时指出，假使新冠病毒像以往其他冠状病毒一样的话，那么新冠疫苗带来的免疫持续时间不会很长，有效期只可以维持半年或者一年。

美国国家过敏和传染病研究所所长Anthony Fauci担忧新冠病毒的潜在疫苗恐“耐用性不佳”，他认为新冠疫苗恐怕无法提供长效免疫力。

据美国全国广播公司商业频道(CNBC)2日报道，Anthony Fauci接受了《美国医学会杂志》(JAMA)编辑Howard Bauchner教授采访时指出，假使新冠病毒像以往其他冠状病毒一样的话，那么新冠疫苗带来的免疫持续时间不会很长，有效期只可以维持半年或者一年。

Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases of the United States, is concerned that the potential vaccine for the new crown virus may be "poorly durable". He believes that the new crown vaccine may not provide long-term immunity.

According to a CNBC report on the 2nd, Anthony Fauci was interviewed by Professor Howard Bauchner, editor of the Journal of the American Medical Association (JAMA), and pointed out that if the new coronavirus is like other coronaviruses in the past, then the new coronavirus vaccine The duration of immunization will not be very long, and the validity period can only last for six months or one year.

Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases of the United States, is concerned that the potential vaccine for the new crown virus may be "poorly durable". He believes that the new crown vaccine may not provide long-term immunity.

According to a CNBC report on the 2nd, Anthony Fauci was interviewed by Professor Howard Bauchner, editor of the Journal of the American Medical Association (JAMA), and pointed out that if the new coronavirus is like other coronaviruses in the past, then the new coronavirus vaccine The duration of immunization will not be very long, and the validity period can only last for six months or one year.

美国国家过敏和传染病研究所所长Anthony Fauci担忧新冠病毒的潜在疫苗恐“耐用性不佳”，他认为新冠疫苗恐怕无法提供长效免疫力。

据美国全国广播公司商业频道(CNBC)2日报道，Anthony Fauci接受了《美国医学会杂志》(JAMA)编辑Howard Bauchner教授采访时指出，假使新冠病毒像以往其他冠状病毒一样的话，那么新冠疫苗带来的免疫持续时间不会很长，有效期只可以维持半年或者一年。

美国新冠首席防疫专家Anthony Fauci博士警告称，其对新冠疫苗的“耐用性”表示担忧，疫苗最终可能无法提供长期的免疫能力。

在接受《美国医学会杂志》（JAMA）采访时，福奇博士表示，如果新冠病毒和其他冠状病毒类似，最终开发出来的疫苗能够提供的免疫时间或许不会很长。

Fauci博士称：“当你回顾冠状病毒的历史，即导致普通感冒的常见冠状病毒”，“具有保护作用的免疫系统的持久性通常不超过1年，一般从3-6个月不等”，“这不是一个很长的保护”。

当被问及科学家是否能够找到有效疫苗时，Fauci博士表示其持“谨慎乐观”态度。其称没有任何东西能够确保科学家可以开发出有效的疫苗，可能需要“数月、数年”的时间才能真正获得答案。

Dr. Anthony Fauci, chief anti-epidemic expert of the New Crown of the United States, warned that he expressed concern about the "durability" of the new crown vaccine, and the vaccine may eventually fail to provide long-term immunity.

In an interview with the Journal of the American Medical Association (JAMA), Dr. Fuch said that if the new coronavirus is similar to other coronaviruses, the vaccine developed in the end may not provide a long immunization time.

Dr. Fauci said: "When you look back at the history of coronaviruses, the common coronaviruses that cause the common cold", "the persistence of the protective immune system usually does not exceed 1 year, generally ranging from 3-6 months", "This is not a very long protection."

When asked if scientists could find an effective vaccine, Dr. Fauci said he was "cautiously optimistic". It said there is nothing to ensure that scientists can develop effective vaccines, and it may take "months and years" to really get an answer.

美国新冠首席防疫专家Anthony Fauci博士警告称，其对新冠疫苗的“耐用性”表示担忧，疫苗最终可能无法提供长期的免疫能力。

在接受《美国医学会杂志》（JAMA）采访时，福奇博士表示，如果新冠病毒和其他冠状病毒类似，最终开发出来的疫苗能够提供的免疫时间或许不会很长。

Fauci博士称：“当你回顾冠状病毒的历史，即导致普通感冒的常见冠状病毒”，“具有保护作用的免疫系统的持久性通常不超过1年，一般从3-6个月不等”，“这不是一个很长的保护”。

当被问及科学家是否能够找到有效疫苗时，Fauci博士表示其持“谨慎乐观”态度。其称没有任何东西能够确保科学家可以开发出有效的疫苗，可能需要“数月、数年”的时间才能真正获得答案。

在接受《美国医学会杂志》（JAMA）采访时，福奇博士表示，如果新冠病毒和其他冠状病毒类似，最终开发出来的疫苗能够提供的免疫时间或许不会很长。

Fauci博士称：“当你回顾冠状病毒的历史，即导致普通感冒的常见冠状病毒”，“具有保护作用的免疫系统的持久性通常不超过1年，一般从3-6个月不等”，“这不是一个很长的保护”。

当被问及科学家是否能够找到有效疫苗时，Fauci博士表示其持“谨慎乐观”态度。其称没有任何东西能够确保科学家可以开发出有效的疫苗，可能需要“数月、数年”的时间才能真正获得答案。

Dr. Anthony Fauci, chief anti-epidemic expert of the New Crown of the United States, warned that he expressed concern about the "durability" of the new crown vaccine, and the vaccine may eventually fail to provide long-term immunity.

In an interview with the Journal of the American Medical Association (JAMA), Dr. Fuch said that if the new coronavirus is similar to other coronaviruses, the vaccine developed in the end may not provide a long immunization time.

Dr. Fauci said: "When you look back at the history of coronaviruses, the common coronaviruses that cause the common cold", "the persistence of the protective immune system usually does not exceed 1 year, generally ranging from 3-6 months", "This is not a very long protection."

When asked if scientists could find an effective vaccine, Dr. Fauci said he was "cautiously optimistic". It said there is nothing to ensure that scientists can develop effective vaccines, and it may take "months and years" to really get an answer.

Can kossan rise to RM23.00?

Can supermax rise to RM35.00?